Fewer Female Mosquitoes, Less Malaria?

Genetic modification approach to control malaria-spreading mosquito populations incites conversations on the ethics of manmade extinction.

Written byTracy Vence
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Anopheles gambiaeWIKIMEDIA, JAMES D. GATHANYResearchers have applied manipulated mosquitoes’ genomes to render the insects less able to spread malaria-causing pathogens. Now, an international team led by investigators at Imperial College London has created a population of genetically modified (GM) Anopheles gambiae that produces predominantly—greater than 95 percent—male offspring, limiting reproduction and, therefore, disease transmission. They published their work in Nature Communications this week (June 10).

“The research is still in its early days, but I am really hopeful that this new approach could ultimately lead to a cheap and effective way to eliminate malaria from entire regions,” study coauthor Roberto Galizi from Imperial College London said in a statement.

Luke Alphey, cofounder of the U.K.-based firm Oxitec, which works to control disease-spreading insects using other genetic techniques, told BBC News that the results of this latest lab study suggest researchers could wipe out A. gambiae entirely. “Humans have undoubtedly driven a very large number of species to extinction, but we’ve only deliberately done it with two: smallpox and rinderpest,” he said. “Would we want to do that with Anopheles gambiae?”

Study coauthor Nikolai Windbichler elaborated on this possibility, telling told ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies